<scp>KRAS</scp> mutation identified in a patient with melorheostosis and extended lymphangiomatosis treated with sirolimus and trametinibClara Lacasta‐Plasín, Minia Campos‐Domínguez, Antonio Cervantes‐Pardo et al.|Clinical Genetics|2021Cited by 8
Author response for "KRAS mutation identified in a patient with melorheostosis and extended lymphangiomatosis treated with sirolimus and trametinib"Clara Lacasta‐Plasín, Minia Campos‐Domínguez, Víctor Martínez‐Glez et al.|Unknown|2021Cited by 0
Author response for "KRAS mutation identified in a patient with melorheostosis and extended lymphangiomatosis treated with sirolimus and trametinib"Clara Lacasta‐Plasín, Minia Campos‐Domínguez, Regina Sánchez-Jiménez et al.|Unknown|2021Cited by 0